Breaking News, Collaborations & Alliances

Celsis, Eurofins Lancaster in Testing Pact

Combines microbio validation and screening with rapid detection platform

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Eurofins Lancaster Laboratories (ELL) and Celsis International have entered into a collaboration through which ELL will provide contract rapid microbiology validation and screening services for Celsis’ rapid detection technology platform. The Celsis rapid detection system allows companies to ensure that products meet microbial specification 60 to 80% faster than traditional methods, according to a company statement. The decrease of as many as seven to 10 days in production cycle times can...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters